Trending News
News
News
WuXi Biologics to Invest in Biologics Manufacturing Facility in Singapore
WuXi Biologics' first overseas site in Asia.
News
First-in-Human Trial Evaluating Ebola Treatment Begins
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114
News
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.
News
New Chemistry to Make Smart Drugs Smarter
A method to activate targeted drugs, or smart drugs, only at the selected site of action, an approach that improves the drug’s therapeutic effect and minimizes side effects, has been developed in a study led by Georgia State University.
News
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.
News
BioAscent Establishes Integrated Drug Discovery Services Offering
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.
News
Lab Innovations returns to the NEC, Bimingham , UK
Save the date for the UK’s only lab-dedicated exhibition showcase!
News
Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia
Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.
News
Immune Cells Hold Promise In Slowing ALS
Recent research showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
News
Single-injection Polio Vaccine
A new nanoparticle vaccine developed by MIT researchers could assist efforts to eradicate polio worldwide. The vaccine, which delivers multiple doses in just one injection, could make it easier to immunize children in remote regions of Pakistan and other countries where the disease is still found.
Advertisement